Literature DB >> 31580252

Molecular Modeling and Docking of Aquaporin Inhibitors to Reveal New Insights into Schistosomiasis Treatment.

Meshari Alazmi1.   

Abstract

BACKGROUND: Schistosomiasis (snail fever/bilharzia), a disease caused by parasitic flatworms (schistosomes), infects millions of people worldwide. Aquaporins from these organisms were found to be a potent drug target.
INTRODUCTION: We investigate the possible mechanism of inhibition of Aquaporin (AQP) from S.mansoni by 5 drug molecules (Praziquantel, Metrifonate, Artimisinin, Albendazole, and Amoscanate).
METHODS: 3D molecular structure of Aquaporin was obtained through homology modeling and further protein-ligand docking and MD simulation were performed.
RESULTS: VAL-75, ASN-91, ALA-220, ASN-222, ARG-225 amino acids were found to play crucial role in ligand binding. TRP-71 and other important residues play major role in hydrophobic interactions stabilizing protein-ligand complexes.
CONCLUSION: We hope that this study (with the newly identified aquaporin target) will support the development of structure and pharmacophore-based novel S. mansoni drugs to control and curb Schistosomiasis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  S. mansoni; Schistosomiasis; aquaporin; homology modeling; molecular docking; molecular dynamics simulation

Year:  2020        PMID: 31580252     DOI: 10.2174/1573409915666191003124947

Source DB:  PubMed          Journal:  Curr Comput Aided Drug Des        ISSN: 1573-4099            Impact factor:   1.606


  2 in total

1.  Exploring the role of Aquaporins (AQPs) in LPS induced systemic inflammation and the ameliorative effect of Garcinia in male Wistar rat.

Authors:  Anuradha Kalita; Manas Das; Momita Rani Baro; Bhabajyoti Das
Journal:  Inflammopharmacology       Date:  2021-06-09       Impact factor: 4.473

2.  Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates.

Authors:  Meshari Alazmi; Olaa Motwalli
Journal:  J Mol Model       Date:  2020-11-11       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.